601
Participants
Start Date
July 31, 2007
Primary Completion Date
April 30, 2008
Study Completion Date
April 30, 2008
Adapalene
0.1% Topical Gel
Differin®
0.1% Topical Gel
Placebo
Gel Base
Helendale Dermatology & Medical Spa, LLC, Rochester
Dermatology Associates of Rochester, PC, Rochester
Novum Pharmaceutical Research Services, Pittsburgh
SNBL Clinical Pharmacology Center, Inc., Baltimore
Office of Zoe Diana Draelos, MD, High Point
MedaPhase, Inc., Newnan
University Clinical Research, Inc., Pembroke Pines
Knoxville Dermatology, PC, Knoxville
University Dermatology Consultants, Inc., Cincinnati
Michigan Center for Research Corportation, Clinton Township
Aurora Advanced Healthcare, Inc., Milwaukee
Dermatology Research of Arkansas, Little Rock
Dermatology Associates of Tyler, Tyler
Arlington Center for Dermatology, Arlington
Center for Clinical Studies, Houston
Center for Clinical Studies, Houston
Cherry Creek Research, Inc., Denver
Academic Dermatology Associates, Albuquerque
Office of Atoya Breona Adams, MD, Las Vegas
Dermatology Research Associates, Los Angeles
Dermatology and Skin Surgery Centre, Belize City
FXM Research International, Belize City
Teva Pharmaceuticals USA
INDUSTRY